Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease-Reference-Cited by-同舟云学术

Phosphate and Coronary Artery Disease in Patients with Chronic Kidney Disease

Published:2024-01-01 Issue:1 Volume:31 Page:1-14
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Ogata Hiroaki¹,Sugawara Hirohito¹,Yamamoto Masahiro¹,Ito Hidetoshi¹

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, Showa University Northern Yokohama Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/31/1/31_RV22012/_pdf

Reference136 articles.

1. 1) Kidney Disease: Improving Global Outcomes CKDMBDWG: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl, 2009; S1-130

2. 2) Kidney Disease: Improving Global Outcomes CKDMBDUWG: KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011), 2017; 7: 1-59

3. 3) Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M, Shibagaki Y, Fukumoto S, Fujii N, Hattori M, Ashida A, Iseki K, Shigematsu T, Tsukamoto Y, Tsubakihara Y, Tomo T, Hirakata H, Akizawa T, Group C-MGW and Japanese Society for Dialysis T: Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial, 2013; 17: 247-288

4. 4) Berndt T and Kumar R: Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol, 2007; 69: 341-359

5. 5) Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D, Disease-Mineral E-EWGoCK, Bone D and the European Renal Nutrition Working G: The role of phosphate in kidney disease. Nat Rev Nephrol, 2017; 13: 27-38

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calciprotein particle counts associate with vascular remodelling in chronic kidney disease;Cardiovascular Research;2024-08-05

2. Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification;Frontiers in Pharmacology;2024-07-31

3. Correlation between serum phosphate and all-cause mortality in critically ill patients with coronary heart disease accompanied by chronic kidney disease: a retrospective study using the MIMIC-IV database;Frontiers in Cardiovascular Medicine;2024-05-31

4. Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor;International Journal of Nephrology and Renovascular Disease;2024-05

5. Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial;Therapeutic Apheresis and Dialysis;2024-03-12